© 1994 Oxford University Press
RESEARCH-ARTICLE |
Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia
Department of Immunology, Rush Medical School Chicago Il 60612 1Department of Pediatrics, Harvard Medical School Boston, MA 02115, USA
*To whom correspondence should be addressed
Received May 27, 1994; Revised August 4, 1994; Accepted August 4, 1994
The defective gene responsible for the recessively inherited immunodeficiency X-linked agammaglobulinemia (XLA) has been shown to encode a cytoplasmic protein tyrosine kinase of the Src family designated Btk (Bruton's tyrosine kinase). To facilitate the search for germline mutations of the Btk gene, we have characterized its genomic structure. Eighteen introns were positioned within the approximately 37 kb gene. Each of the exon/intron boundaries were defined and sequenced, and all but two conform to consensus sequences. We have utilized the genomic organization of Btk and the intervening sequence data to design an assay for amplifying each of the 19 exons from XLA patient DNA for single strand conformation polymorphism (SSCP) analysis. By using this method we have identified mutations in 12 of 14 unrelated affected males: seven different base substitutions and two small deletions. Two of the mutations described in exon 15 of the kinase domain were found in more than one patient and may represent a mutation hot spot. Exon scanning has proven to be a valuable method for identifying the patient mutations in genomic DNA without the use of cDNA. The mutations are easily confirmed with direct sequencing of the amplified exons. This approach will greatly benefit XLA family studies involving carrier detection and prenatal diagnosis. In addition, the mutations identified may reveal residues involved in the specific protein interactions necessary in the B-cell developmental pathway, of which Btk is an integral component.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E.-K. Jo, H. Kanegane, S. Nonoyama, S. Tsukada, J.-H. Lee, K. Lim, M. Shong, C.-H. Song, H.-J. Kim, J.-K. Park, et al. Characterization of Mutations, Including a Novel Regulatory Defect in the First Intron, in Bruton's Tyrosine Kinase Gene from Seven Korean X-Linked Agammaglobulinemia Families J. Immunol., October 1, 2001; 167(7): 4038 - 4045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Futatani, T. Miyawaki, S. Tsukada, S. Hashimoto, T. Kunikata, S. Arai, M. Kurimoto, Y. Niida, H. Matsuoka, Y. Sakiyama, et al. Deficient Expression of Bruton's Tyrosine Kinase in Monocytes From X-Linked Agammaglobulinemia as Evaluated by a Flow Cytometric Analysis and Its Clinical Application to Carrier Detection Blood, January 15, 1998; 91(2): 595 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Minegishi, E. Coustan-Smith, Y.-H. Wang, M. D. Cooper, D. Campana, and M. E. Conley Mutations in the Human {lambda}5/14.1 Gene Result in B Cell Deficiency and Agammaglobulinemia J. Exp. Med., January 5, 1998; 187(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rohrer and M. Ellen Conley Transcriptional Regulatory Elements Within the First Intron of Bruton's Tyrosine Kinase Blood, January 1, 1998; 91(1): 214 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Oeltjen, T. M. Malley, D. M. Muzny, W. Miller, R. A. Gibbs, and J. W. Belmont Large-Scale Comparative Sequence Analysis of the Human and Murine Bruton's Tyrosine Kinase Loci Reveals Conserved Regulatory Domains Genome Res., April 1, 1997; 7(4): 315 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yel, Y. Minegishi, E. Coustan-Smith, R. H. Buckley, H. Trubel, L. M. Pachman, G. R. Kitchingman, D. Campana, J. Rohrer, and M. E. Conley Mutations in the Mu Heavy-Chain Gene in Patients with Agammaglobulinemia N. Engl. J. Med., November 14, 1996; 335(20): 1486 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. S. Rosen, M. D. Cooper, and R. J.P. Wedgwood The Primary Immunodeficiencies N. Engl. J. Med., August 17, 1995; 333(7): 431 - 440. [Full Text] [PDF]
|
|